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osting by EAbstract Background: Diabetes mellitus is a vascular disease with many microvascular manifes-
tations as retinopathy and macrovascular complications as coronary artery disease. A large number
of diabetics with retinopathy may have unidentiﬁed coronary artery disease.
Objective: Evaluate whether diabetic retinopathy is a valid predictor of coronary artery disease.
Study design: Cross section study.
Patients and methods: The study included 60 male patients chosen randomly from diabetic and
ophthalmologic outpatient clinics. Twenty patients had type 2 diabetes mellitus with nonprolifera-
tive retinopathy, 20 patients with proliferative diabetic retinopathy and 20 patients with type 2 dia-
betes mellitus without retinopathy. All studied cases were not previously identiﬁed as coronary
artery disease. Clinical examination stressed on conventional cardiovascular risk factors; duration,
degree of control of hyperglycemia and erectile failure. Lipogram, urinary albumin excretion, rest-
ing, exercise ECG and echocardiography were carried out. All patients were subjected to fundus
examination for evaluation of diabetic retinopathy and duplex ultrasound to assess carotid intimal
medial thickness. Coronary angiography was undertaken for all cases.
Results: There was no signiﬁcant difference regarding age, BMI and blood pressure between the
groups. However, duration of diabetes, erectile dysfunction and neuropathy revealed signiﬁcant
difference between different groups particularly the proliferative in relation to the nonprolifera-
tive diabetic group. Hypertriglyceridimia, urinary albumin excretion and serum cholesterol differm (W. Refaie).
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64 F. El Demerdash et al.signiﬁcantly between the studied groups. The ECG, echocardiography showed insigniﬁcant dif-
ferences. Carotid intima media thickness showed an insigniﬁcant difference when comparing the
three studied groups, however diabetic retinopathy group with coronary artery stenosis revealed
a signiﬁcant increase in carotid media thickness. Evidence of coronary artery stenosis was pres-
ent in 80% of the proliferative diabetic retinopathy group and in 70% of the nonproliferative
diabetic retinopathy group but was not present in nonretinopathic diabetic group. The stenotic
lesions were involving one or two vessels. No one had left main disease.
Conclusion: Diabetic retinopathy is a good predictor of coronary artery disease that exceeds the
conventional risk factors. Diabetics with retinopathy would beneﬁt from early coronary angiog-
raphy and diabetic retinocoronary clinics are warranted.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Chronic hyperglycemia results in microvascular and macrovas-
cular complications.1 Diabetes is among the most important
risk factors for coronary artery disease (CAD). The microvas-
cular complications like diabetic retinopathy (DR) usually
play a critical role in the life of diabetics. Fioretto et al.2 re-
ported that for the prevention of progression of vasculopathy
early detection is needed.
Weckbach et al.3 reported a high prevalence of occult ath-
erosclerotic disease in DM and CAD may be silent in more
than two thirds of long standing diabetics. Hernadez et al.4
concluded that true silent myocardial ischemia is a highly pre-
valent condition in type 2 diabetics especially in males and
those with DR.
Some clinical ﬁndings may lead to suspecting CAD. Erectile
dysfunction (ED) is frequently associated with multiple cardio-
vascular (CV) risk factors and complications like DR and
CAD.5 The presence of xanthlasma that would suspect dyslipi-
demia was found to be signiﬁcantly related to instent restenosis
(Sukhija et al.).6 DR may be an independent risk marker for
CVD (Gimeno-Orna et al.).7
1.1. Study design
Cross section study.
1.2. Aim
To identify whether conventional atherosclerosis risk factors
be a greater linking for CAD in long standing type 2 diabetic
patients and to elucidate whether DR and/ or cIMT be valid
predictors of CAD.
2. Subjects and methods
The study included 60 patients with long standing type 2
(>10 years) Diabetes mellitus; 20 patients with proliferative
diabetic retinopathy, 20 patients with nonproliferative diabetic
retinopathy and 20 diabetic patients without retinopathy. They
were randomly chosen from diabetic and ophthalmologic out-
patient clinics. All were males with a mean age of
46.19 ± 0.9 years. Smokers were excluded. Diagnosis of DR
was based on ophthalmoscopic examination and fundus pho-
tography. The examined groups were age and sex matched.
Clinical examination stressed on conventional CV risk factors,
duration of diabetes and degree of hyperglycemia, BMI and
erectile dysfunction. Laboratory investigations were performedstressing on lipogram,8 urinary albumin excretion9 and HBA1-
c.10 Resting ECG, exercise treadmill test and echocardiography
were performed. Painless myocardial ischemia was considered
positive when there was no chest pain inspite of 1 mm or more
ST segment depression during the exercise stress tests.11 Coro-
nary angiography was undertaken for all the studied cases.
All patients were also subjected to duplex ultrasound to assess
carotid intima media thickness (cIMT). Cases have been fully
informed about the study that was approved by the cardiovas-
cular department ethical committee and consents were taken.
2.1. Statistical analysis
Statistical analysis was performed by using the statistical
package for social science program (SPSS) version ‘‘16’’. The
qualitative data were presented as frequency and percentages.
The quantitative data were examined by using Kalmogrov–
Smirnov test to test for normal distribution of the data and
when parametric, expressed as mean and standard deviation.
Student t test was used, to test for differences in normally dis-
tributed quantitative data between the two groups. Mann–
Whitney-l test was used for comparison between two groups
when data are not normally distributed. Signiﬁcance was con-
sidered when P value was less than 0.05.
3. Results
No signiﬁcant difference was found between the three groups
regarding age, BMI, SBP, DBP (Table 1). On the other hand
duration of diabetes was signiﬁcantly longer in both the retino-
pathic groups compared to the nonretinopathic group. Fre-
quency of peripheral neuropathy as well as erectile
dysfunction was higher in both retinopathic groups compared
to NRD (Tables 2–5).
HBA1-c was signiﬁcantly elevated in both PDR and non-
PDR in comparison to the NRD group. Serum cholesterol,
TG were signiﬁcantly elevated in PDR in comparison to the
NRD group while, there were no statistical differences be-
tween the nonPDR and NRD groups. The HDL-cl showed
insigniﬁcant difference. The UAE were signiﬁcantly elevated
in both PDR and nonPDR when compared to the NRD
group.
Resting ECG showed insigniﬁcant difference between the
studied diabetic group while stress ECG demonstrated that
15% of PDR and 10% of nonPDR and only 5% of nonretino-
pathic group had silent ischemia (P1 mm ST segment depres-
sion without chest pain). cIMT showed insigniﬁcant
differences when comparing the three studied groups but the
Table 1 Demographic and clinical characteristics of the examined cases.
DPR(1) 20 cases DNPR (2) 20 cases NRD(3) 20 cases P1–3 P2–3
Age (years) 47.1 ± 1.9 46.19 ± 1.9 46.21 ± 0.9 0.066 0.96
Duration of DM (years) 11.1 ± 1.1 10.1 ± 1.2 8.9 ± 1.3 <0.001 0.004
BMI 33.1 ± 1.1 32.5 ± 1.1 32.2 ± 2.9 0.201 0.667
BP (mmHg)
SBP 143.1 ± 4.6 142.2 ± 4.5 141.1 ± 1.9 0.079 0.319
DBP 90.87 ± 1.1 91.69 ± 2.9 91.1 ± 1.1 0.531 0.399
PN 28.22 ± 2.5 26.11 ± 1.7 20.12 ± 1.7 <0.001 <0.001
Chest pain no. (%) 3/20 (15%) 2/20 (10%) 1/20 (5%) 0.291 0.553
Erectile dysfunction no. (%) 10/20 (50%) 8/20 (40%) 2/20 (10%) 0.006 0.030
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cant increased cIMT.
Echocardiographic evidences of diastolic dysfunction were
present in 6, 5, 4 cases of the studied PDR, nonPDR and the
nonretinopathic diabetic groups respectively. Coronary angi-
ography performed on all the studied diabetic groups revealed
CA stenosis in 80% of the PDR, 70% of the nonPDR and was
absent in the nonretinopathic group. The differences were sta-
tistically signiﬁcant.
Comparing all the stenotic cases (30 cases) to the nonste-
notic cases (30 cases) illustrated that the risk factors of athero-
sclerosis were signiﬁcantly more evident in the stenotic CAD in
comparison to the nonstenotic CAD. Stenotic CAD was more
evident in PDR (80%) than the nonPDR (70%) and was not
present in the NRD group. cIMT showed insigniﬁcant differ-
ences when comparing the three studied groups but calculating
the difference between stenotic lesions the nonstenotic groups
demonstrated a signiﬁcant increase in cIMT than in the ste-
notic CAD group.
4. Discussion
The studied cases were recruited from diabetic and ophthalmo-
logic clinics for the study assessment. They were known to be
long standing diabetics. Patients with other traditional risk fac-
tors for atherosclerosis were not included. Smokers, known
hypertensive and those under hypotensives or antidyslipidem-
ics were excluded. Clinical examination revealed signiﬁcant dif-
ferences between the retinopathic and the nonretinopathic
groups in the presence of the history of erectile dysfunction
and peripheral neuropathy.
History of ED was present in 50%, 40% and 10% of the
PDR, nonPDR and NRD groups respectively. This is lower
than that reported by Hermans et al.12 who found the
frequency of ED in the retinopathic groups to be 84.3%.
This could be attributed to the difference in the way of detect-
ing ED. Males with ED in our region may mask their EDTable 2 The studied CV risk factors.
DPR(1) 20 cases DNPR (2) 20
HBA1-c 9.01 ± 0.9 8.09 ± 1.1
Cholesterol (mg/dl) 233.9 ± 12.9 200.5 ± 15.7
Triglyceride (mg/dl) 201.8 ± 11.1 170.1 ± 22.1
LDL-cl (mg/dl) 140.29 ± 10.9 137.26 ± 12.5
HDL-cl (mg/dl) 38.25 ± 7.9 36.40 ± 6.8
UAE mg/24 h 360.35 ± 22.9 280.90 ± 21.2considering that ED is against manhood. Hermans et al.12 re-
ported that ED is now considered a surrogate marker of endo-
thelial dysfunction as well as a sentinel predictor of new onset
macroangiopathic events.
HBA1-c which is an index of the degree of control of the
hyperglycemic state was found to be elevated in the three stud-
ied groups. Higher HBA1-c was found to be one of the impor-
tant factors related to the development of PDR.13–15
Serum TG was signiﬁcantly elevated in the studied diabetic
groups especially in PDR. The Fenoﬁbrate Intervention and
Event Lowering in Diabetes (FIELD) study support the use
of fenoﬁbrate for CVD and DR prevention16
The present ﬁnding of a signiﬁcant elevation of UAE in dia-
betics with retinopathy conﬁrms the ﬁndings of Parving et al.17
and Savage et al.14 who found that UAE is more than an indi-
cator of renal disease in NIDDM patients and in fact may re-
ﬂect a state of generalized vascular damage that occurs
throughout the body. Tong et al.18 concluded that in patients
with type 2 DM, retinopathy interacts with microalbuminuria
to increase the risk of CV events. Donnelly et al.19 proved that
UAE rate is associated with 2–4 fold increases in CV and all
cause mortality.
Resting ECG showed insigniﬁcant changes in relation to
the different DR groups while exercise stress ECG revealed
that 15%, 10% and 5% have ischemic changes in PDR, non-
PDR and NDR groups respectively. This is coinciding with
Bailey and Sparrow20 who found that only 15% of diabetics
with CAD could have ECG changes. Positive exercise ECG
testing in patients with DR was reported many decades
ago.21 The lower frequency of silent ischemia in the present
study is not in accordance with Nakagawa et al.11 who found
silent ischemia in 69% but are in agreement with Hernadez et
al.4 who detected silent ischemia in 21.9%.
Echocardiography evidences LV diastolic dysfunction in
PDR together with signiﬁcant prolonged relaxation and
delayed abnormal valve opening. The peak rates of cavity
dimension increase and posterior wall thinning were reducedcases NRD (3) 20 cases P1–3 P2–3
7.99 ± 1.2 0.004 0.016
190.90 ± 17.9 <0.001 0.091
160.8 ± 11.9 <0.001 0.105
134.24 ± 0.5 0.017 0.286
35.49 ± 7.2 0.255 0.683
260.29 ± 24.1 <0.001 0.006
Table 5 Patients with stenotic CAD lesions versus nonstenotic CAD.
DR with stenotic lesions 30 cases DR without stenotic lesions 30 cases P
Age 60.6 ± 1.9 57.84 ± 1.3 <0.001
Duration of DM 12.01 ± 0.9 9.05 ± 1.1 <0.001
HBA1-c 9.01 ± 0.9 8.05 ± 1.1 0.0004
BP
SBP 150.39 ± 1.9 140.12 ± 1.9 <0.001
DBP 90.87 ± 0.6 92.90 ± 2.2 <0.001
TG 201.8 ± 11.1 160.8 ± 11.9 <0.001
UAE 360.35 ± 22.9 280.90 ± 21.2 <0.001
cIMT 1.11 ± 0.05 1.01 ± 0.1 0.001
Table 3 ECG, echocardiography.
DPR (1) 20 cases DNPR (2) 20 cases NRD (3) 20 cases P1–3 P2–3
Resting ECG ischemia 3/20 (15%) 2/20 (10%) 1/20 (5%) 0.297 0.553
Exercise stress ECG ischemia 3/20 (15%) 2/20 (10%) 1/20 (5%) 0.297 0.553
Diastolic dysfunction 6/20 (30%) 5/20 (25%) 4/20 (20%) 0.470 0.708
cIMT 1.09 ± 0.2 1.08 ± 0.1 1.07 ± 0.3 0.917 0.888
Table 4 Coronary angiographic affection.
No of C vessels involved DPR (1) 20 cases DNPR (2) 20 cases NRD (3) 20 cases P1–3 P2–3
One vessel 8/20 (40%) 8/20 (40%) 0 <0.001 <0.001
Two vessels 8/20 (40%) 6/20 (30%) 0 <0.001 0.008
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mental hypokinesia were not reported in any of the studied
groups.
Measuring cIMT revealed insigniﬁcant differences when
comparing the three studied groups but the DR group with ste-
notic CAD lesion showed a signiﬁcant increase in cIMT. The
insigniﬁcant differences in the cIMT between the three studied
groups although are different from most studies yet they are in
accordance with Adams et al.22 who found that the relation-
ship between the cIMT and the severity of CAD is weak.
The present ﬁnding of a signiﬁcant increase in cIMT in the ste-
notic CAD group is conﬁrmatory to many studies.23–25
The present ﬁndings are in accordance with those of Koch
et al.26 who found that the clinical symptoms as well asconventional CV risk proﬁle are not valid predictors of CAD
and that coronary angiography should be performed in all dia-
betics prior to renal transplantation. Williams et al.27 found
combined microvascular and macrovascular sequelae in 24%
of diabetics.
Coronary angiography is the surest method and the corner-
stone for diagnosing CAD,27 although not always feasible in
many cardiovascular units in developing countries.
Reaching no deﬁnitive diagnosis of CAD, coronary angiog-
raphy was accepted and performed for the studied cases. 80%
of patients with PDR and 70% of patients with nonPDR had
signiﬁcant stenotic CAD lesion. This is coinciding with many
recent studies.28,7,29,30 In the present study; old age, longer
duration of DM and uncontrolled hyperglycemic state were
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the nonstenotic group. Ohno et al.29 reported that patients
with DR having a signiﬁcant stenotic CAD and needing early
CABG might well go unrecognized to face serious cardiac
events; cardiac death, MI and repeat revascularization.31 B
mode carotid US as a useful measure of CAD23,24 was previ-
ously conﬁrmed by the autopathy studies which showed that
the extent of carotid and CAD are coinciding.32 In the present
study cIMT revealed insigniﬁcant differences on comparing
the three studied groups although it was signiﬁcantly thicker
in the stenotic CAD group.
Diagnosis of DR is an easy outpatient clinical maneuver.
Its presence is a call for a complete evaluation for CVD risk
factors together with stress ECG, echocardiography and coro-
nary angiography and measuring cIMT. The present ﬁndings
are conﬁrmatory to Targher et al.33 and Cheung et al.34 who
concluded that DR especially in its more advanced stages is
associated with an increased CVD and CHD risk independent
of other known CV risk factors. The present results are also
coinciding with Gimeno-Orna et al.7 who found that DR is
an independent risk marker for CAD and also conﬁrmatory
to Baiely and Sparrow,20 who found that 24% of diabetics
with retinopathy have angina and myocardial infarction. The
availability of PCI and CABG intervention nowadays man-
dates coronary angiography for type 2 diabetic patients espe-
cially in the presence of increased cIMT and DR with or
without conventional CV risk factors.355. Conclusion
Long standing diabetics should undergo repeated fundus
examination at least yearly not only for preserving their vision
but also for early suspicion of CAD events. Detection of DR
and/ or increased cIMT should be a trigger to investigate
CAD and coronary angiography has to be performed once ret-
inopathy is diagnosed and special diabetic retinocoronary clin-
ics are warranted.References
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